Friendly bacteria gel could tame eczema flares
NCT ID NCT06504160
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial is testing whether a gel containing beneficial bacteria (Staphylococcus hominis A9) can safely control eczema flares. About 86 adults and children aged 6 and older will apply the gel or a placebo twice daily for 14 weeks, along with a short course of steroid cream. The goal is to see if the bacteria help keep eczema under control longer after steroids are stopped.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Staphylococcus hominis A9 (ShA9) bacteria in a topical gel
What this could lead to
If it works, this could offer a new way to manage eczema by using friendly bacteria to prevent flares, reducing the need for steroids.
What could go wrong
This is an early Phase 1 trial with only 86 participants, so results are preliminary. The gel may not work better than placebo, and there could be skin reactions or other side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center: Asthma Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology
RECRUITINGNew York, New York, 10029, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Jewish Health: Division of Pediatric Allergy and Clinical Immunology
RECRUITINGDenver, Colorado, 80206, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
New York University Langone Health: Department of Pediatric Allergy and Immunology
TERMINATEDNew York, New York, 10016, United States
-
Northwestern University Feinberg School of Medicine: Department of Dermatology
RECRUITINGChicago, Illinois, 60611, United States
Contact
Contact Email: •••••@•••••
-
University of California, San Diego: Dermatology Clinical Trials Unit
RECRUITINGSan Diego, California, 92093, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Rochester Medical Center: Department of Dermatology
RECRUITINGRochester, New York, 10029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Wisconsin School of Medicine and Public Health: Division of Pediatric Allergy, Immunology and Rheumatology
RECRUITINGMadison, Wisconsin, 53792, United States
Contact
Contact Email: •••••@•••••